Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
27 July 2018Website:
http://www.adialpharma.comNext earnings report:
21 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 19:17:16 GMTDividend
Analysts recommendations
Institutional Ownership
ADIL Latest News
Making millions through the stock market is only possible in a few ways. Investors need one of these three things: Massive sums of capital to begin with Decades of time and more modest sums of capital More modest sums of capital and a combination of risk and luck We will be talking about the latter today: seven stocks you can buy for $2 that can 10X by 2025.
GLEN ALLEN, Va., May 29, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it will be participating in the Spring MicroCap Rodeo Conference that will be held on Thursday, June 6, 2024 in New York City.
Adial Pharmaceuticals Inc (NASDAQ: ADIL) saw a 60% increase in its stock today after announcing positive results for its alcohol disorder drug. The Virginia-based company, valued at $7.7 million, reported promising results for its AD04 drug in a clinical trial involving patients with Alcohol Use Disorder (AUD).
Adial Pharmaceuticals (NASDAQ: ADIL ) stock is on the rise today after receiving favorable results from a peer review of its Alcohol Use Disorder ( AUD ) treatment. The focus of this peer review was on the Phase 3 clinical trial outcomes for AD04.
Adial Pharmaceuticals, Inc. (ADIL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CHARLOTTESVILLE, VA / ACCESSWIRE / October 19, 2023 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it will be participating in the Fall Foliage MicroCap Rodeo Conference that will be held virtually Tuesday, October 24th through Friday, October 27th, 2023. Cary Claiborne, CEO of Adial Pharmaceuticals, is scheduled to present on Wednesday, October 25th, at 10:30 a.m.
CHARLOTTESVILLE, Va., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that Cary Claiborne, CEO of Adial Pharmaceuticals, will be participating in the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023 at the Lotte New York Palace Hotel in New York City.
Here is how Adial Pharmaceuticals, Inc. (ADIL) and Adverum Biotechnologies (ADVM) have performed compared to their sector so far this year.
What type of business is Adial Pharmaceuticals?
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
What sector is Adial Pharmaceuticals in?
Adial Pharmaceuticals is in the Healthcare sector
What industry is Adial Pharmaceuticals in?
Adial Pharmaceuticals is in the Biotechnology industry
What country is Adial Pharmaceuticals from?
Adial Pharmaceuticals is headquartered in United States
When did Adial Pharmaceuticals go public?
Adial Pharmaceuticals initial public offering (IPO) was on 27 July 2018
What is Adial Pharmaceuticals website?
https://www.adialpharma.com
Is Adial Pharmaceuticals in the S&P 500?
No, Adial Pharmaceuticals is not included in the S&P 500 index
Is Adial Pharmaceuticals in the NASDAQ 100?
No, Adial Pharmaceuticals is not included in the NASDAQ 100 index
Is Adial Pharmaceuticals in the Dow Jones?
No, Adial Pharmaceuticals is not included in the Dow Jones index
When does Adial Pharmaceuticals report earnings?
The next expected earnings date for Adial Pharmaceuticals is 21 August 2024